Investments
Onkos Surgical develops personalized implant solutions for orthopedic oncologists, trauma, and revision surgeons using specialized software, imaging, and 3D printing technology.
jsdradius.comCrawled Nov 8, 2026
Onkos Surgical develops personalized implant solutions for orthopedic oncologists, trauma, and revision surgeons using specialized software, imaging, and 3D printing technology.
Quisque egestas lacus ut sem ultricies, eget vulputate turpis fermentum. Praesent lobortis finibus dui, vitae commodo nulla gravida sit amet. Donec a ultrices ex. Suspendisse luctus in leo quis sollicitudin. Etiam dolor enim, pellentesque nec tincidunt vitae, laoreet sit amet tortor. Duis nec sagitt
Duis ornare placerat molestie. Etiam volutpat nisl quis leo tincidunt, a hendrerit felis convallis. Sed tempus orci id faucibus auctor. Morbi consequat nulla quis volutpat varius. Integer id placerat metus. Etiam quis felis nec lorem vehicula pellentesque. Ut vitae venenatis dolor. Proin condimentum
In laoreet imperdiet metus, pharetra consectetur velit porta quis. Nam non libero sem. Morbi justo nulla, sagittis a mauris eget, bibendum mollis nunc. Praesent rutrum nunc tincidunt pellentesque volutpat. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Cl
Nulla volutpat, erat ac blandit imperdiet, est lacus egestas ex, sit amet lacinia risus ante a lorem. Ut elementum, velit non luctus aliquam, nibh odio molestie lectus, id faucibus felis augue id mauris. Sed porta posuere fringilla. Donec feugiat risus sit amet tortor venenatis, non venenatis nisl b
Onkos Surgical expands access to NanoCept Antibacterial Technology for patients requiring total femoral replacement
Iantrek Raises $23M Series B Financing to Advance Next Generation Ophthalmic Micro-Interventional Technologies
Arthur Halper led operations for entrepreneurial businesses and large corporations in health informatics and managed care. He served as a Senior Operations Executive for Cerberus Operations and Advisory Company (COAC) from 2006 to 2014, supporting acquisitions including Steward Healthcare System LLC.
Vincent S. Conti has been a Venture Partner of Radius Ventures since 2010. He previously managed acute care hospitals, including as President and CEO of Maine Medical Center from 1997 to 2008.
George Milne Jr., Ph.D. has been a Venture Partner of Radius Ventures since 2003. He spent over 30 years at Pfizer Inc. in management roles, including Executive Vice President of Pfizer Global Research and Development.
Thomas F. O’Donnell, Jr., M.D. retired as Senior Vascular Surgeon at Tufts Medical Center and served as President and CEO of Tufts New England Medical Center Hospitals from 1996 to 2004. He is now Chief Medical Officer of Tactile Systems Technology (NASDAQ: TCMD).
Scott Garrett is a Senior Operating Partner at Water Street Healthcare Partners. He previously led global healthcare businesses in diagnostics, life sciences, and medical products, including as Chairman, President, and CEO of Beckman Coulter from 2008 to 2011.
Jordan S. Davis is Managing Partner and Founder of JSD Capital, LLC, the investment advisor to the Radius Special Situations funds, focused on venture-stage and growth equity investments in transformative, technology-driven health and life sciences companies.
JSD Capital, LLC focuses on venture-stage and growth equity investments in health and life sciences companies, leveraging founder Jordan Davis’s 35 years of experience.
This privacy policy applies to JSD Capital, LLC and the Radius Special Situations funds.